Several types of cancer are characterized by global hypomethylation accompanied by regional 25 hypermethylation and overexpression of DNA methyltransferase (cytosine-5) 1 (Dnmt1). In 26 addition to the established role of Dnmt1 as maintenance methyltransferase, it has been 27 suggested that Dnmt1 might also methylate certain target sites de novo. We created a 28 transgenic mouse model to investigate whether the overexpression of the somatic form of 29 Dnmt1, Dnmt1s, is sufficient to cause erroneous methylation and disease. Because ubiquitous 30 Dnmt1 overexpression has been reported to be embryonic lethal, we designed a CAG 31 promoter-driven Cre-loxP conditional transgene containing a floxed EGFP sequence followed 32 by the Dnmt1s coding sequence. The EGFP sequence is excised and transgenic Dnmt1s 33 expression is activated at specific time points or in specific tissues depending on the Cre 34 deleter strain used for cross-ins. Pronucleus injections with the Dnmt1s transgene construct 35 resulted in six founder lines as verified by PCR, Southern blot and EGFP fluorescence. We 36 performed cross-ins with a CMV-Cre deleter strain to clarify if ubiquitous overexpression of 37 Dnmt1s alone causes the previously observed embryonic lethality. Unexpectedly, these cross-38 ins yielded viable recombined offspring that ubiquitously overexpressed Dnmt1 mRNA at 39 tissue-dependent levels of up to 229-fold. However, the recombined offspring did not 40 significantly overexpress Dnmt1 protein and showed no apparent signs of disease or 41 pathological phenotype. Here, we describe the establishment of our Dnmt1s-transgenic mouse 42 model and propose possibilities for the absence of transgenic protein.
Introduction 44 45 DNA methylation is an important part of epigenetic signaling and is involved in 46 differentiation, X-inactivation and genomic imprinting (Bird 2002 The HSV-TK promoter was cloned into a basic vector with no promoter (pGL4.10[luc2], 140 Promega) to generate a HSV-TK-driven reporter construct that contained the GCCACC was excised from the agarose gel and purified using the Qiaquick Gel Extraction Kit (Qiagen, 175 Hilden, Germany), strictly following the manufacturer's protocol, except that the DNA was We generated a conditional Cre-loxP transgene construct (pLCAG-EGFP-loxP-Dnmt1s) for 262 the overexpression of Dnmt1s in mice. The transgene was constructed to initially express an 263 EGFP marker protein ubiquitously driven by the CMV immediate early enhancer/chicken 264 beta-actin promoter/rabbit beta-globin intron composite (CAG) promoter (Niwa et al. 1991 ).
265
The EGFP sequence of the transgene is flanked by loxP sites (Fig. 1A ). Upon recombination 266 with Cre recombinase, the sequence between the loxP sites is looped out, removed and 267 degraded by cellular mechanisms, preventing its re-insertion ( Fig. 1B) . Due to the excision of transgenic mice showed strong EGFP expression ( Fig. 3A, B ). EGFP was also expressed in 304 the paws (Fig. 3C, D) , ears, nose, kidney, spleen and liver (data not shown) from mice 305 carrying the unrecombined transgene, giving solid evidence that the transgene was 306 successfully inserted and CAG-driven expression of the transgene was ubiquitous.
307
In addition to fluorescence microscopy, PCR and Southern blots were performed to 308 verify transgene insertion. The PCR primers spanned a region from the EGFP sequence into the Dnmt1s sequence, so that a 532 bp product indicated successful transgene insertion ( Fig.   310 3E). The PCR reaction was multiplexed with primers spanning a region of the endogenous 311 Rag1 gene, so a 295 bp product indicated a successful PCR procedure. The Southern blot 312 served as another control for transgene insertion. The transgenic status was indicated by one 313 or more signals additional to those produced by the endogenous Dnmt1 (Fig. 3F ). with DNase (on column and in solution) to make sure that they were free of genomic DNA.
345
Transgenic Dnmt1s mRNA was expressed in recombined mice at different levels in a tissue-346 dependent manner, with highest levels in heart and skeletal muscle (Fig. 4B ). Wild type 347 siblings did not yield any RT-PCR products (Fig. S1 ).
348
To compare the expression levels of Dnmt1 mRNA between transgenic mice and wild S4A) on translation. We cloned the different Kozak sequences used in our mouse model into a 387 standard luciferase reporter plasmid and measured their influence on translation (Fig. S4B ).
388
The Kozak sequence used in our Dnmt1s transgene cassette (TTCCCC) reduced protein 389 expression to about 70% compared to the Kozak sequence from the EGFP cassette, which had 390 the optimal Kozak consensus (GCCACC) sequence (Fig. 7) . To more closely resemble the 391 situation in our mouse model, we tested the same two Kozak sequences using a luciferase 392 reporter vector carrying an N-terminal RGS-His 6 tag identical to the one in our mouse model 393 (Fig. S4B) . The RGS-His 6 tag reduced the luciferase activity to about 30% in both cases, 394 independent of the Kozak sequence ( Fig. 7) . 
406
They generated Dnmt1-overexpressing mice using a BAC clone that included all three 407 isoforms of Dnmt1, leaving unclear which isoform(s) triggered the embryonic lethal 408 phenotype. Therefore, we cloned a transgene using the murine cDNA of the somatic isoform,
409
Dnmt1s, while leaving out the oocyte-and spermatocyte-specific isoforms, and generated a 410 mouse model for its conditional overexpression to circumvent embryonic lethality and study 411 long-term consequences.
412
We created a Cre-loxP transgene construct (Hoess & Abremski 1985) so that shortened. The CAG promoter that drives our transgene carries its own 5'UTR and an intron 461 from the rabbit beta-globin gene and has successfully been used for the expression of intron- In summary, we generated three independent Dnmt1s-transgenic mouse lines.
495
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